Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Mohammed I A, Hamed"'
Autor:
Rofida Albash, Rania Moataz El-Dahmy, Mohammed I. A. Hamed, Khaled M. Darwish, Abdulrahman M. Alahdal, Amira B. Kassem, Abdurrahman M. Fahmy
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2784-2795 (2022)
Levocetirizine hydrochloride (LVC) is an antihistaminic drug that is repurposed for the treatment of alopecia. This investigation is targeted for formulating LVC into cationic ceramide/phospholipid composite (CCPCs) for the management of alopecia. CC
Externí odkaz:
https://doaj.org/article/c7975c27b1a646248532a2f1ebcb5bc2
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 922-939 (2021)
Novel tolmetin derivatives 5a–f to 8a–c were designed, synthesised, and evaluated for antiproliferative activity by NCI (USA) against a panel of 60 tumour cell lines. The cytotoxic activity of the most active tolmetin derivatives 5b and 5c was ex
Externí odkaz:
https://doaj.org/article/a5bf88daf2174d419c766822e5d1d416
Autor:
Rofida Albash, Noha M. Badawi, Mohammed I. A. Hamed, Maha H. Ragaie, Sahar S. Mohammed, Rovan M. Elbesh, Khaled M. Darwish, Manar O. Lashkar, Sameh S. Elhady, Shaimaa Mosallam
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 128 (2023)
The foremost target of the current work was to formulate and optimize a novel bergamot essential oil (BEO) loaded nano-phytosomes (NPs) and then combine it with spironolactone (SP) in order to clinically compare the efficiency of both formulations ag
Externí odkaz:
https://doaj.org/article/8fd88ce59d0647a6a7a938578da745fb
Autor:
Soha H. Emam, Rasha A. Hassan, Eman O. Osman, Mohammed I. A. Hamed, Amr M. Abdou, Mai M. Kandil, Eman Maher Elbaz, Demiana S. Mikhail
Publikováno v:
Drug Development Research. 84:475-499
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c5f0ff48f137b7e20eb89a4c05e4abb
https://doi.org/10.1002/ddr.22037
https://doi.org/10.1002/ddr.22037
Autor:
Momen R. Fareed, Mai E. Shoman, Mohammed I. A. Hamed, Mohamed Badr, Hanin A. Bogari, Sameh S. Elhady, Tarek S. Ibrahim, Gamal El-Din A. Abuo-Rahma, Taha F. S. Ali
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1114 (2021)
A series of 3-benzylideneindolin-2-one compounds was designed and synthesized based on combretastatin A-4 and compound IC261, a dual casein kinase (CK1)/tubulin polymerization inhibitor, taking into consideration the pharmacophore required for EGFR-t
Externí odkaz:
https://doaj.org/article/1fa090297e6e4a839f74fdf924fcba24
Autor:
Ayman Abo Elmaaty, Mohammed I. A. Hamed, Muhammad I. Ismail, Eslam B. Elkaeed, Hamada S. Abulkhair, Muhammad Khattab, Ahmed A. Al-Karmalawy
Publikováno v:
Molecules, Vol 26, Iss 12, p 3772 (2021)
The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority for human beings due to the severity of the global health pandemic caused by COVID-19. To this end, repurposing of FDA-approved drugs such as NSAIDs against COVID-19 can provide th
Externí odkaz:
https://doaj.org/article/d4be711eb925420f8b5bd4b8ea4d7431
Autor:
Onur Bender, Mai E. Shoman, Taha F. S. Ali, Rumeysa Dogan, Ismail Celik, Adriano Mollica, Mohammed I. A. Hamed, Omar M. Aly, Abdulwahab Alamri, Jowaher Alanazi, Nafees Ahemad, Siew Hua Gan, Jonaid Ahmad Malik, Sirajudheen Anwar, Arzu Atalay, Eman A. M. Beshr
© 2022 Deutsche Pharmazeutische Gesellschaft.FMS-like tyrosine kinase 3 (FLT3) mutations occur in approximately 30% of acute myeloid leukemia (AML) patients. In the current study, the oxindole chemotype is employed as a structural motif for the desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d5ff4f7959d2be383b58d7c2e2c0795
https://avesis.kayseri.edu.tr/publication/details/d884dc06-2f71-4655-b390-d6825e034682/oai
https://avesis.kayseri.edu.tr/publication/details/d884dc06-2f71-4655-b390-d6825e034682/oai
Autor:
Ahmed A. Al-Karmalawy, Amani Chrouda, Raya Soltane, Hamada S. Abulkhair, Ahmed Mostafa, Ahmed E. Khodir, Sameh S. Elhady, Noura M. Abo Shama, Ayman Abo Elmaaty, Mohammed I. A. Hamed, Khaled M. Darwish
Publikováno v:
RSC Advances. 11:35536-35558
The global COVID-19 pandemic became more threatening especially after the introduction of the second and third waves with the current large expectations for a fourth one as well. This urged scientists to rapidly develop a new effective therapy to com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::506218f3e686beef22d7bda7a35b7710
https://doi.org/10.1039/d1ra04820a
https://doi.org/10.1039/d1ra04820a
Autor:
Rofida, Albash, Abdurrahman M, Fahmy, Mohammed I A, Hamed, Khaled M, Darwish, Rania Moataz, El-Dahmy
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Spironolactone (SP) is a potassium sparing diuretic with antiandrogenic properties. This study aimed at formulating SP into hyaluronic acid enriched cerosomes (HAECs) for topical management of hirsutism. HAECs were prepared by ethanol injection metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::238899d11bfb6c4efc43026ae0354df4
https://pubmed.ncbi.nlm.nih.gov/34726545
https://pubmed.ncbi.nlm.nih.gov/34726545
Autor:
Taha F.S. Ali, Tarek S. Ibrahim, Momen R. Fareed, Mohammed I. A. Hamed, Mai E. Shoman, Sameh S. Elhady, Gamal El-Din A. Abuo-Rahma, M. M. Badr, Hanin A. Bogari
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1114, p 1114 (2021)
Pharmaceuticals
Volume 14
Issue 11
Pharmaceuticals
Volume 14
Issue 11
A series of 3-benzylideneindolin-2-one compounds was designed and synthesized based on combretastatin A-4 and compound IC261, a dual casein kinase (CK1)/tubulin polymerization inhibitor, taking into consideration the pharmacophore required for EGFR-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa9fddf64c1bb331e43ea84e5f69218c
https://www.mdpi.com/1424-8247/14/11/1114
https://www.mdpi.com/1424-8247/14/11/1114